Two different studies from Pennsylvania and Philadelphia groups have reported that from 30 patients with ALL that received anti‐CD19 CAR‐T‐cell therapy, 27 cases (90%) indicated complete remission.57 The gene discussed is CD19; the disease is acute lymphoblastic leukemia.